News

The Greater Bay Area International Clinical Trial Institute (GBAICTI), The Greater Bay Area International Clinical Trials Center (BAY TRIAL) and Health Hope Pharma (HHP) today signed a Memorandum of Understanding (MoU) to establish a strategic collaboration framework for advancing new drug development and conducting international multi-centre clinical trials in Hong Kong and across the wider Guangdong-Hong Kong-Macao Greater Bay Area (GBA).

We welcome the launch of the public consultation on “The First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)”, a significant milestone that sets out a forward-looking vision and strategic direction for the city’s development. The Plan provides an important framework to support Hong Kong’s high-quality development and its deeper integration into the overall national development agenda.

Join us as GBAICTI convenes leaders across the clinical research ecosystem to advance collaboration and innovation.